Search Results

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 1)

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 1)

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 1 of 3)

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 1 of 3)

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 2)

Public Meeting: Patient-Focused Drug Development for Chronic Pain (Part 2)

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)

Public Meeting: Patient-Focused Drug Development for Neuropathic Pain (Part 2 of 3)

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1

Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1

Public Meeting on Patient Focused Drug Development for Functional GI Disorders Part 1

Public Meeting on Patient Focused Drug Development for Functional GI Disorders Part 1

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 2 of 2)

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 2 of 2)

Public Meeting on Patient Focused Drug Development for HIV Part 1

Public Meeting on Patient Focused Drug Development for HIV Part 1

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1

Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1

Public Meeting on Patient Focused Drug Development for Sickle Cell Disease Part 1

Public Meeting on Patient Focused Drug Development for Sickle Cell Disease Part 1

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 1)

Public Meeting: Patient-Focused Drug Development for Huntington’s and Parkinson’s Disease (Part 1)